APA (7th ed.) Citation

Eman El-Khateeb, Eman El-Khateeb, Eman I. El-Berri, Esraa M. Mosalam, Mohamed Z. Nooh, Shimaa Abdelsattar, . . . Mahmoud S. Abdallah. (2023). Evaluating the safety and efficacy of the leukotriene receptor antagonist montelukast as adjuvant therapy in obese patients with type 2 diabetes mellitus: A double-blind, randomized, placebo-controlled trial. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Eman El-Khateeb, Eman El-Khateeb, Eman I. El-Berri, Esraa M. Mosalam, Mohamed Z. Nooh, Shimaa Abdelsattar, Amira M. Alghamdi, Sarah Alrubia, and Mahmoud S. Abdallah. Evaluating the Safety and Efficacy of the Leukotriene Receptor Antagonist Montelukast as Adjuvant Therapy in Obese Patients with Type 2 Diabetes Mellitus: A Double-blind, Randomized, Placebo-controlled Trial. Frontiers Media S.A., 2023.

MLA (9th ed.) Citation

Eman El-Khateeb, et al. Evaluating the Safety and Efficacy of the Leukotriene Receptor Antagonist Montelukast as Adjuvant Therapy in Obese Patients with Type 2 Diabetes Mellitus: A Double-blind, Randomized, Placebo-controlled Trial. Frontiers Media S.A., 2023.